Recommendations for the use of clinical outcome assessments in rare disease drug development
- DOI
- 10.1016/j.eclinm.2026.104073
- Published
- 2026-08
- Container
- eClinicalMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2026.104073,
title = {Recommendations for the use of clinical outcome assessments in rare disease drug development},
author = {Olalekan Lee Aiyegbusi and Noleen K. McCorry and Melanie J. Calvert and John Devin Peipert and Samantha Cruz Rivera and Robert Muni-Lofra and Solomon Alexis and Fez Awan and Tom Bailey and Lucinda Billingham and Rosaline Callaghan and Christine Collins and Brooke M. Currie and Mel Dixon and Melanie Duddridge and James Ennis and Linda Fred and Sarah Greenwell and Christian Griffiths and Asha Hareendran and Onyekachukwu A. Illoh and Kerry Leeson-Beevers and Krishna Letchemanan and Steven P. Lister and Christopher McCabe and Molly McFatrich and Amy Jayne McKnight and Fiona McLaughlin and Ramona Moldovan and Lindsey T. Murray and Daniel J. O'Connor and Hafiz Oko-osi and Louise Oni and Kate M. Pritchard and Khadija Rerhou Rantell and Volker Straub and Timothy G. Barrett and David Jones and Michael Clarke and Hayley Comins and Simon Gates and Amber R. Hart and Victoria Hedley and Blánaid Hicks and Martin R. Higgs and Matthew Hosken and Ameeta Retzer and Sarah Scullion and Laura A. Wyatt and Steven J. Blackburn and Catherine Turner},
year = {2026},
journal = {eClinicalMedicine},
doi = {10.1016/j.eclinm.2026.104073},
url = {https://doi.org/10.1016/j.eclinm.2026.104073}
}RIS
TY - JOUR TI - Recommendations for the use of clinical outcome assessments in rare disease drug development AU - Olalekan Lee Aiyegbusi AU - Noleen K. McCorry AU - Melanie J. Calvert AU - John Devin Peipert AU - Samantha Cruz Rivera AU - Robert Muni-Lofra AU - Solomon Alexis AU - Fez Awan AU - Tom Bailey AU - Lucinda Billingham AU - Rosaline Callaghan AU - Christine Collins AU - Brooke M. Currie AU - Mel Dixon AU - Melanie Duddridge AU - James Ennis AU - Linda Fred AU - Sarah Greenwell AU - Christian Griffiths AU - Asha Hareendran AU - Onyekachukwu A. Illoh AU - Kerry Leeson-Beevers AU - Krishna Letchemanan AU - Steven P. Lister AU - Christopher McCabe AU - Molly McFatrich AU - Amy Jayne McKnight AU - Fiona McLaughlin AU - Ramona Moldovan AU - Lindsey T. Murray AU - Daniel J. O'Connor AU - Hafiz Oko-osi AU - Louise Oni AU - Kate M. Pritchard AU - Khadija Rerhou Rantell AU - Volker Straub AU - Timothy G. Barrett AU - David Jones AU - Michael Clarke AU - Hayley Comins AU - Simon Gates AU - Amber R. Hart AU - Victoria Hedley AU - Blánaid Hicks AU - Martin R. Higgs AU - Matthew Hosken AU - Ameeta Retzer AU - Sarah Scullion AU - Laura A. Wyatt AU - Steven J. Blackburn AU - Catherine Turner PY - 2026 JO - eClinicalMedicine DO - 10.1016/j.eclinm.2026.104073 UR - https://doi.org/10.1016/j.eclinm.2026.104073 ER -
APA
Aiyegbusi, O. L., McCorry, N. K., Calvert, M. J., Peipert, J. D., Rivera, S. C., Muni-Lofra, R., Alexis, S., Awan, F., Bailey, T., Billingham, L., Callaghan, R., Collins, C., Currie, B. M., Dixon, M., Duddridge, M., Ennis, J., Fred, L., Greenwell, S., Griffiths, C., Hareendran, A., Illoh, O. A., Leeson-Beevers, K., Letchemanan, K., Lister, S. P., McCabe, C., McFatrich, M., McKnight, A. J., McLaughlin, F., Moldovan, R., Murray, L. T., O'Connor, D. J., Oko-osi, H., Oni, L., Pritchard, K. M., Rantell, K. R., Straub, V., Barrett, T. G., Jones, D., Clarke, M., Comins, H., Gates, S., Hart, A. R., Hedley, V., Hicks, B., Higgs, M. R., Hosken, M., Retzer, A., Scullion, S., Wyatt, L. A., Blackburn, S. J., & Turner, C. (2026). Recommendations for the use of clinical outcome assessments in rare disease drug development. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104073
Source records
- crossref · retrieved 2026-09-25T21:00:06.913Z